Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Ashwani Gujral of ashwanigujral.com recommends buying IndusInd Bank, HDFC and Ajanta Pharma.
Mitessh Thakkar of miteshthacker.com is of the view that one can buy Ajanta Pharma and can sell ICICI Bank.
Ashwani Gujral of ashwanigujral.com recommends buying Glenmark Pharma, Ajanta Pharma and Cipla.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy L&T, Asian Paints, Whirlpool of India, Sun TV Network and Bajaj Finance and advises selling Ajanta Pharma and Dish TV.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy NMDC and hold Adani Ports and Special Economic Zone while can sell PVR and Ajanta Pharma and avoid Lupin.
Ruchit Jain of Angel Broking advices buying selling Apollo Hospital with a target of Rs 1030.
Rajat Bose of rajatkbose.com advises buying Ajanta Pharma around Rs 1100.
Moneycontrol analysed pharma stocks with a market cap of over Rs 1,000 crore. In order to find out if there are any scrips available at a reasonable valuation, we used five-year average price-to-earnings as a filter
Ashwani Gujral of ashwanigujral.com is of the view that one can sell Ajanta Pharma and PVR and buy Delta Corp.
Sudarshan Sukhani of s2analytics.com recommends selling Ajanta Pharma, Balkrishna Industries and IDFC Bank and advises buying Indraprastha Gas and Colgate Palmolive.
Ashwani Gujral of ashwanigujral.com is of the view that one may sell Ajanta Pharma, DLF and BF Utilities and buy Edelweiss Financial Services and Jubilant Foodworks.
Sudarshan Sukhani of s2analytics.com is of the view that one may buy United Breweries, Asian Paints and Hindustan Unilever and can sell Ajanta Pharma and Indian Oil Corporation.
Ashish Kyal of Waves Strategy Advisors is of the view that one may buy Biocon with a target of Rs 418.
Sudarshan Sukhani of s2analytics.com suggests buying HDFC, HDFC Bank, PC Jeweller, Bharti Infratel and Adani Ports and Special Economic Zone and advises selling Torrent Power and Ajanta Pharma.
Vishvesh Chauhan of Monarch Networth Capital advises buying Bank of India with a target of Rs 151.
Sudarshan Sukhani, s2analytics.com is of the view that one may buy Ajanta Pharma, Bharat Financial Inclusion, Escorts and Godrej Consumer Products and can sell Apollo Hospitals Enterprises.
The risk-to-reward ratio will be more favourable for stocks which have not attracted too much of interest which could be due to the sector or stock-specific reasons.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy HUL, HDFC Bank and Tata Elxsi and can sell Ajanta Pharma and Zee Entertainment.
According to Prakash Gaba of prakashgaba.com, there is a good chance that the Nifty could see positive move in the last day of the F&O expiry. The crucial support for the Nifty is at 9466-9439-9400 and the resistance is at 9560-9591 while Bank Nifty has support at 22950 and resistance at 23500.
Sudarshan Sukhani of s2analytics.com advises selling Amara Raja Batteries and Ajanta Pharma.
Mitessh Thakkar of mitesshthakkar.com advises selling V-Guard Industries and Yes Bank.
Mitessh Thakkar of miteshthacker.com suggests buying Can Fin Homes and advises selling Ajanta Pharma.
Ruchit Jain of Angel Broking is of the view that one may buy Ajanta Pharma with a target of Rs 1745.
Nifty has support at 9375-9312 and resistance at 9500 while Bank Nifty has support at 22450-22400 and resistance at 22800, says Prakash Gaba of prakashgaba.com.
Prakash Gaba of prakashgaba.com is of the view that Tata Motors can climb to Rs 465 while Ajanta Pharma looks good for target of Rs 1725.